Brigitte Dréno

Research interests

Publications

• The Skin Microbiome: A New Actor in Inflammatory Acne

  American Journal of Clinical Dermatology · 2020 · https://doi.org/10.1007/s40257-020-00531-1

• Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

  The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30379-6

• Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates

  Journal of the European Academy of Dermatology and Venereology · 2018 · https://doi.org/10.1111/jdv.15043

• Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

  The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)31266-7

• Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

  The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)31266-7

• Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial

  The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30231-0

• Predictors of responses to immune checkpoint blockade in advanced melanoma

  Nature Communications · 2017 · https://doi.org/10.1038/s41467-017-00608-2

• Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

  Clinical Cancer Research · 2016 · https://doi.org/10.1158/1078-0432.ccr-15-2412

• Microbiome in healthy skin, update for dermatologists

  Journal of the European Academy of Dermatology and Venereology · 2016 · https://doi.org/10.1111/jdv.13965

• Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial

  The Lancet Oncology · 2016 · 10.1016/s1470-2045(16)30122-x

• Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

  New England Journal of Medicine · 2015 · 10.1056/nejmoa1504030

• Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma

  New England Journal of Medicine · 2014 · 10.1056/nejmoa1408868

• Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

  The Lancet Oncology · 2014 · 10.1016/s1470-2045(14)70012-9

• Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma

  Journal of Clinical Oncology · 2013 · 10.1200/jco.2012.44.6112

• European Evidence‐based (S3) Guidelines for the Treatment of Acne

  Journal of the European Academy of Dermatology and Venereology · 2012 · 10.1111/j.1468-3083.2011.04374.x

• Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

  New England Journal of Medicine · 2012 · 10.1056/nejmoa1203421

• Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group

  Zurich Open Repository and Archive (University of Zurich) · 2012 · 10.5167/uzh-63198

• Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

  New England Journal of Medicine · 2011 · 10.1056/nejmoa1103782

• EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma*

  Blood · 2011 · https://doi.org/10.1182/blood-2011-05-351346

• New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne Group

  Journal of the American Academy of Dermatology · 2009 · 10.1016/j.jaad.2009.01.019

• A Single Cycle of Rituximab for the Treatment of Severe Pemphigus

  New England Journal of Medicine · 2007 · 10.1056/nejmoa067752

• Defining early mycosis fungoides

  Journal of the American Academy of Dermatology · 2005 · https://doi.org/10.1016/j.jaad.2005.08.057

• Management of Acne

  Journal of the American Academy of Dermatology · 2003 · 10.1067/mjd.2003.618

• A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid

  New England Journal of Medicine · 2002 · 10.1056/nejmoa011592

• Identification of SLC39A4, a gene involved in acrodermatitis enteropathica

  Nature Genetics · 2002 · 10.1038/ng913

• Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma

  Journal of Clinical Oncology · 2000 · 10.1200/jco.2000.18.1.158

• Randomised trial of interferon α-2a as adjuvant therapy in resected primary melanoma thicker than 1·5 mm without clinically detectable node metastases

  The Lancet · 1998 · 10.1016/s0140-6736(97)12445-x

• Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens

  The Lancet · 1998 · 10.1016/s0140-6736(97)08496-1

Current projects

No projects listed.